Premium
Wide scope prenatal diagnosis at Kuopio University Hospital 1997 ‐ 1998: integration of gene tests and fetal karyotyping
Author(s) -
Kallinen Juuso,
Marin Katja,
Hein Seppo,
Mannermaa Arto,
Palotie Aarno,
Ryynänen Markku
Publication year - 2001
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2001.00118.x
Subject(s) - prenatal diagnosis , fetus , medicine , genotyping , prenatal screening , genetic counseling , genetic testing , pediatrics , obstetrics , carrier testing , karyotype , pregnancy , genotype , genetics , gene , biology , chromosome
Objective To investigate the applicability of carrier screening in women undergoing invasive prenatal diagnosis. Design Prospective study. Setting University‐based clinic. Participants Two hundred and fifty‐six pregnant women. Methods Gene tests were offered for fragile X syndrome, aspartylglycosaminuria and infantile neuronal ceroid lipofuscinosis at the time of invasive prenatal testing. Results The overall uptake of the tests was 92%. Previously unrecognised carriership was found in 10 women: aspartylglycosaminuria (7); infantile neuronal ceroid lipofuscinosis (2) and fragile X (1). Fetal genotyping was carried out in one carrier of aspartylglycosaminuria whose partner was also a carrier, and in one woman who was found to have fragile X premutation. Both fetuses were unaffected. Conclusion Carrier screening for single‐gene disorders is feasible and well accepted among pregnant women undergoing invasive prenatal testing. The major benefit is that there is no need to consider extra invasive tests when carriership is detected. Incorporation of genetic testing into fetal karyotyping gives more security to future parents.